Simulated proof asset · India Healthcare GrowthOS

Simulated India dermatology clinic WhatsApp + DPDP diagnostic

This no-fake-client proof asset shows how AICS can inspect dermatology and aesthetic patient-growth leakage across missed calls, WhatsApp, Instagram, paid-search, referral and camp enquiries before a clinic scales ads, AI admin follow-up or no-show recovery. It is synthetic only: no real clinic, patient, PHI, medical outcome, DPDP compliance, booking, revenue or ROI claim is made.

Important claim boundary: this page is a simulated proof-of-method demonstration. It is not a customer case study, not a testimonial, not a patient-data analysis, and makes no real clinic, no patient, no medical advice, no legal advice, no privacy advice, no security advice, no DPDP attestation, no appointment, no no-show, no advertising, no ranking, no revenue and no ROI promise.
Synthetic enquiries1,58312 synthetic workflow/channel rows
After-hours enquiries235sample events needing callback ownership
Missed calls69synthetic calls not initially answered
Callback coverage proxy53.9%after-hours + missed-call base with callback in 2 hours
Consults booked520synthetic booking status only
Booked not attended153synthetic no-show/late-cancel proxy
DPDP notice prompt gap1,486rows needing evidence before claims
Offer/claim review gap1,383aesthetic wording needing human review route
Diagnostic method

What a dermatology or aesthetic clinic owner can inspect before scaling ads, WhatsApp or AI admin follow-up

The diagnostic converts enquiry rows into operating queues: source tagging, owner/counsellor assignment, callback SLA, consent/notice evidence, AI/admin boundary disclosure, clinical escalation routes, aesthetic offer-claim review, closure reasons and no-show recovery.

Evidence/control areaSynthetic enquiry volume with gapWhy AICS would flag it
Source captured733Owners cannot reliably compare Google Business Profile calls, WhatsApp, Instagram, ads, referrals, review sites and camp sheets.
Owner/counsellor assigned1,210Unowned treatment-interest rows make callbacks and follow-up accountability weak.
DPDP notice prompt present1,486The workflow lacks operational evidence that data-use notice language was presented; this is not compliance advice.
WhatsApp opt-in evidence1,583Follow-up templates should distinguish permissioned patient/prospect messages from ad hoc staff messaging.
AI/admin boundary disclosed1,102Prospects should not confuse automated triage or admin assistance with dermatologist or qualified clinician judgment.
Clinical escalation route858Automation needs a staff route for medical symptoms, medication history, complications and urgent questions.
Offer/claim review route1,383Aesthetic discount wording, before/after-photo requests and treatment promises need human review before reuse.
No-show recovery route1,583Booked-but-not-attended records need recovery ownership before more ad spend.
Closure reason captured1,583Unresolved rows need reasons such as price objection, treatment concern, timing, duplicate, spam or clinical escalation.

Before diagnostic

  • Reception and counsellors handle enquiries across phone, WhatsApp, Instagram DMs, ad forms, review sites and camp sheets.
  • The owner sees consultations and attendance counts but cannot trace which channels lack follow-up ownership.
  • DPDP notice wording, WhatsApp opt-in evidence and AI/admin boundary prompts are inconsistent.
  • Aesthetic offer language and clinical escalation rely on staff memory instead of a documented review route.

After diagnostic operating rule

  • Each channel becomes a lightweight evidence row with source, owner, treatment interest, callback time, status, notice prompt and closure reason fields.
  • A weekly owner memo shows missed-call backlog, no-show recovery backlog, source attribution gaps and evidence prompt gaps.
  • Automation is constrained until WhatsApp opt-in, AI/admin boundary wording, offer-claim review and clinical escalation routes are reviewed.
  • Source hygiene, callback SLA, no-show recovery and counsellor queue tasks are assigned visibly.

Evidence needed before publishing any real dermatology clinic outcome

A real pilot should collect only permissioned, minimized operational exports where possible; define callback SLA and owner rules; document consultation/no-show status, notice/purpose prompts, WhatsApp opt-in handling, AI/admin boundary wording, aesthetic offer-claim review and clinical escalation routes; and obtain explicit clinic approval plus qualified legal/privacy/advertising/clinical review before any public patient, DPDP, booking, revenue or ROI statement.

Reproducibility

Internal synthetic artifact: /home/agent/.hermes/aicloudstrategist/case-studies/simulated-india-dermatology-aesthetic-clinic-whatsapp-dpdp-2026-08-20/. Expected headline output: rows=12, total_enquiries=1583, after_hours_enquiries=235, missed_calls=69, callback_coverage_pct=53.9, consults_booked=520, consults_attended=367, synthetic_booked_not_attended=153, synthetic_attendance_rate_pct=70.6, dpdp_notice_prompt_gap_enquiries=1486, whatsapp_optin_evidence_gap_enquiries=1583, offer_claim_review_route_gap_enquiries=1383, no_show_recovery_route_gap_enquiries=1583. Input SHA256 3e4fdf3075f004687412876c750c727d0c6869032edb254952301023352d24c1; generator SHA256 045b6423f024bf453cca8e0f5905d26b6fd756fa6a92337bb7469506eba35d61; report SHA256 32a03a41d4f0dbf2f8e5e223c26fd0bc14c3f807bb1eb13f6c72f0d3fa89b69d.

More proof assets · WhatsApp lead follow-up checklist · Healthcare GrowthOS · Resources